Our Team

Jinsung Kim
CEO
James Sohn
CEO-US
Jaehee Chun
CSO
Seonggong Moon
CTO
Minkyung Jeon
COO
Doil Jung
Sales Director
Yong Bae Kim
Medical Advisor
Sang joon Shin
Medical Advisor
Jee Suk Chang
Medical Advisor

Our History

2024
05 EN ISO 13485:2016 certified  I  View certificate
03
Signed research contract with University of Chicago
2023
01 Signed MoU with Elketa
05 Signed MoU with Weknew
08 Established Oncosoft USA Inc.
08 Signed contract with Japan M3 AI
09 Signed MoU with Yonsei Digital Health Center
10 Held the 1st User Meeting ‘OncoBUS’
11 Signed MoU with Terapet SA
11 Signed MoU with Yonsei Cancer Hospital Heavy Ion Therapy Center
12 Signed contract with Gachon University Gil Medical Center
2022
02 Acquired KFDA class II medical device certification for AI-based  auto-segmentation solution
03 Commercialized OncoStudio (AI-based auto segmentation SW)
09 Investment of KRW 35B (Series A)
2021
03 Established Corporate R&D Center
07 Investment of KRW 500M (Series Pre-A)
11 Acquired Good Manufacturing Practice (GMP) certification for medical  device manufacturing and quality management
2020
10 Investmentof KRW 150M (Seed)
2019
10 Ranked3rd in AAPM’s ‘RT-MAC Challenge’
09 Established Oncosoft  Co., Ltd

Go beyond with Oncosoft

Subscribe to learn about upgrades and services for our product.